These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of monoclonal antibodies in the in situ identification of T-cell subpopulations in cutaneous T-cell lymphoma. Chu AC J Cutan Pathol; 1983 Dec; 10(6):479-98. PubMed ID: 6363476 [No Abstract] [Full Text] [Related]
3. Differential loss of T lymphocyte markers in advanced cutaneous T cell lymphoma. Holden CA; Staughton RC; Campbell MA; MacDonald DM J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):507-13. PubMed ID: 7042776 [No Abstract] [Full Text] [Related]
4. Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. Berger CL; Morrison S; Chu A; Patterson J; Estabrook A; Takezaki S; Sharon J; Warburton D; Irigoyen O; Edelson RL J Clin Invest; 1982 Dec; 70(6):1205-15. PubMed ID: 6217214 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies]. Kikuchi K Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817 [TBL] [Abstract][Full Text] [Related]
6. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells. Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877 [TBL] [Abstract][Full Text] [Related]
7. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma. Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889 [TBL] [Abstract][Full Text] [Related]
8. Cell lineage analysis in cutaneous lymphoid infiltrates using a panel of monoclonal antibodies reactive in wax-embedded tissue. van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA Curr Probl Dermatol; 1990; 19():124-31. PubMed ID: 2404673 [No Abstract] [Full Text] [Related]
9. Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies. Rosen ST; Zimmer AM; Goldman-Leikin R; Kazikiewicz JM; Dykewicz MS; Silverstein EA; Spies SM; Kaplan EH Int J Rad Appl Instrum B; 1989; 16(6):667-8. PubMed ID: 2606722 [No Abstract] [Full Text] [Related]
10. Cutaneous T cell lymphoma. Lymphocyte phenotype analysis after anti-thymocyte globulin therapy. Hunter RF; Roth PA; Huang AT Am J Med; 1985 Nov; 79(5):653-8. PubMed ID: 3877463 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody patterns in cutaneous lymphoid infiltrates. Their possible relevance to the diagnosis and categorization of cutaneous lymphomas. McMillan EM Dermatol Clin; 1985 Oct; 3(4):593-603. PubMed ID: 2947768 [TBL] [Abstract][Full Text] [Related]
12. Dual expression of T and B cell markers in human B cell neoplasias. Herrmann F; Lochner A; Enders B; Komischke B; Rühl H Acta Haematol; 1983; 69(5):319-25. PubMed ID: 6404114 [TBL] [Abstract][Full Text] [Related]
13. [Immunologic phenotyping of cutaneous lymphomas]. Kaudewitz P; Burg G; Smolle J; Braun-Falco O Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828 [TBL] [Abstract][Full Text] [Related]
14. [Use of monoclonal antibodies in hematology]. Pagnucco G; Bernasconi C Riv Emoter Immunoematol; 1984; 31(1):1-35. PubMed ID: 6085185 [No Abstract] [Full Text] [Related]
15. Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Carney DN; Bunn PA; Schechter GP; Gazdar AF Int J Cancer; 1980 Nov; 26(5):535-42. PubMed ID: 6972355 [TBL] [Abstract][Full Text] [Related]